Susan Froshauer (co-founder Rib-X Pharmaceuticals now Melinta)

Susan Froshauer served as President and CEO of CURE (now BioCT) from 2013 through Oct 2017. BioCT provides education, entrepreneurial resources, and advocates on behalf of the bioscience industry in Connecticut.

Earlier in her career she was a co-founder and CEO of Rib-X Pharmaceuticals (now Melinta). During her 11 year tenure she led the company through 0mm of investment and development of novel antibiotic treatments. #SGWomen

Startup Grind Local features incredible talks with entrepreneurs from Startup Grind’s world wide network. Startup Grind is a global startup community designed to educate, inspire, and connect entrepreneurs.
Subscribe to Startup Grind Local: https://www.youtube.com/user/StartupGrindLocal
Startup Grind on YouTube: https://www.youtube.com/user/StartupGrind
Follow us on Twitter: https://twitter.com/StartupGrind
Like us on Facebook: https://www.facebook.com/StartupGrind
Find a Startup Grind event in your area: www.startupgrind.com

At “Rib-X Pharmaceuticals” in New Haven, nearly forty researchers are working on some of the most perplexing problems of modern medicine. They’re working on a cure for those highly anti-biotic resistant super bugs, like MRSA.
Video Rating: / 5